This afternoon (August 21), the New Area will hold the first launch of the alternative commercial health insurance ceremony for high -level talents and a seminar in the digitalization of commercial medical insurance and medical health, and released the first regional exclusive alternative health insurance product products in the country, "New Area Blue Bay Plan B" B "). It was reported that the product was launched by the first National Insurance Company organized in the new Lingang area, together launched by the Lingang New Area Medical Device Innovation中心,JUN HEALTH,中国重新保险和其他机构。产品保护范围的消耗品。它旨在改善人才服务系统,以帮助开发“科学技术创新城市”,同时,商业保险在不断变化的医学和设备支付机制中的作用,改善了新区域的现代药物和设备的访问和可用性。 Shenneng Insurance个人保险部副总经理Mingqiang表示,“ Blue Bay Plan B”的核心将为削减医疗技术提供“优先访问”和“方便付款”。该项目专用于该设备上的新药物和新疗法,这些疗法尚未涵盖临床实践,但尚未涵盖医疗保险,并建立了与Blue Bay Plan B Plan Blan Plan Plans一致的新药和新设备的清单,并保持了动态。据报道,当前列表包括第一个用于淋巴瘤的CAR-T细胞疗法,“ Yikaida", and the accurate endoradiotherapy "Dofigo" drug confirmed to the clinically significantly extend the safety of patients with bone metastasis in prostate cancer. In terms of payment protection, "Blue Bay Plan B" also produces successes, such as full compensation for special drugs for malignant tumors, buying drugs is used within limit, and the full payment for public special needs for serious illnesses is given to high -level talents, trying to solve the problem “ Akakaya”还发现,该项目还创建了一个企业的群体,并可以确保五个症状的员工。 - 科学NA国际专业人才的Pang-Industriya Na Talent Pamilya在Pagkatapos Ay Bumubuo ng Isang Magkasanib na Puwersa na Mage Mga Patakaran Sa Talento Talthero Tulad ng Trabaho在Pag-areglo的Pag-areglo smart atuse fien the yin in。新的管理委员会表示,该项目的实施将促进新的Lingang地区的生物制药行业的发展。“预计有望加深保险业与生物制药行业之间的合作,促进双方的合作和发展,从而推出更合适的新药,新设备和新消耗品。保险”。目前,它专注于招募高端医疗设备公司,以提供研究和开发,临床评论,现实世界研究以及对医疗设备进行大量数据加强的医疗设备市场管理的基本数据支持,从而促进了高端医疗设备的研究和开发,转型和工业化。新领域的E医疗设备创新中心表示,“行业,教育,研究和保险”的联合建设和整合损害了行业的传统障碍,该障碍允许研发设备,研发产品完成以及风险管理操作的结束,从一开始就进行对话。例如,对于慢性疾病管理(例如高血压和糖尿病),事件发生后传统保险是支付的,并且不会干扰该过程。通过不断监视可用的设备并建立数据分析和算法模型,企业可以从跟踪数据中提取有效的健康风险指标。基于这些数据和模型,保险公司可以设计保险产品的动态价格(例如合规性奖励),以生成自动承保和控制系统。